HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Neutrogena "Renova compatible" line positioned as a "serious skin care program".

This article was originally published in The Rose Sheet

Executive Summary

NEUTROGENA SKIN CARE PRODUCTS TO BE MARKETED AS "RENOVA COMPATIBLE," the Johnson & Johnson personal care subsidiary said. Following the Dec. 29 approval of J&J subsidiary Ortho Pharmaceutical's Renova (tretinoin emollient cream .05%) as an antiwrinkling agent ("The Rose Sheet" Jan. 8, p. 4), Neutrogena is repackaging a series of skin care products to include the phrase "clinically tested Renova compatible" on the product label. The five products will be positioned as a "serious skin care program" that will meet the needs of Renova users, and will be available to consumers in April in mass-market outlets.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002414

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel